A detailed history of Hb Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hb Wealth Management, LLC holds 42,569 shares of LLY stock, worth $32.1 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
42,569
Previous 41,460 2.67%
Holding current value
$32.1 Million
Previous $37.5 Million 0.47%
% of portfolio
0.41%
Previous 0.44%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $856,303 - $1.06 Million
1,109 Added 2.67%
42,569 $37.7 Million
Q2 2024

Jul 26, 2024

BUY
$724.87 - $909.04 $1.99 Million - $2.5 Million
2,745 Added 7.09%
41,460 $37.5 Million
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $652,012 - $872,300
1,101 Added 2.93%
38,715 $30.1 Million
Q4 2023

Jan 16, 2024

BUY
$525.19 - $619.13 $999,436 - $1.18 Million
1,903 Added 5.33%
37,614 $21.9 Million
Q3 2023

Oct 13, 2023

SELL
$434.7 - $599.3 $5.49 Million - $7.57 Million
-12,633 Reduced 26.13%
35,711 $19.2 Million
Q2 2023

Jul 13, 2023

BUY
$350.74 - $468.98 $11.2 Million - $15 Million
32,016 Added 196.08%
48,344 $22.7 Million
Q1 2023

Apr 13, 2023

SELL
$310.63 - $364.82 $79,210 - $93,029
-255 Reduced 1.54%
16,328 $5.61 Million
Q4 2022

Jan 20, 2023

BUY
$321.55 - $374.67 $556,924 - $648,928
1,732 Added 11.66%
16,583 $0
Q3 2022

Oct 19, 2022

SELL
$296.48 - $337.87 $169,586 - $193,261
-572 Reduced 3.71%
14,851 $4.8 Million
Q2 2022

Jul 15, 2022

BUY
$278.73 - $327.27 $139,365 - $163,635
500 Added 3.35%
15,423 $5 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $597,755 - $742,858
2,547 Added 20.58%
14,923 $4.27 Million
Q4 2021

Feb 15, 2022

BUY
$224.85 - $279.04 $2.78 Million - $3.45 Million
12,376 New
12,376 $3.42 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $716B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hb Wealth Management, LLC Portfolio

Follow Hb Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hb Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hb Wealth Management, LLC with notifications on news.